At K2019 global market leaders to young spin-offs present their impressive capabilities. High-calibre trade visitors from over 100 countries make use of K as the ideal business platform for information and investment.
For nearly two decades, the BioJapan exhibition has played an pivotal role in promoting interaction between Japan and global organizations and in spuring new business opportunities. In October 2019, the world’s top business development, licensing and alliance management, R&D…
ZeCardio Therapeutics (ZeCardioTx), a pharma company focused on the discovery of cardiovascular drugs using the zebrafish model and a proprietary screening platform, ZeCardio®, selected Taros’ SVP Drug Discovery, Dr. Torsten Hoffmann, to join…
The 17th edition of Annual Discovery on Target (DOT), the industry’s premier event for novel drug targets and technologies, will bring together more than 1,300 drug discovery experts from September 16 to 19, 2019 in Boston, Massachusetts USA. Target Validation Strategies for the Discovery and…
We are transforming your ideas into products
We provide long-term added value to our diverse customers through cutting-edge and innovative chemistry-based technologies
Taros creates holistic and cost-effective solutions of the highest quality and reliability for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. tThereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.